scholarly journals P.07.15 MEGASTENT®: A NEW OPTION FOR THE ENDOSCOPIC TREATMENT OF STAPLE-LINE LEAK AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY

2013 ◽  
Vol 45 ◽  
pp. S140
Author(s):  
L. Magno ◽  
S. Ruggiero ◽  
T. Russo ◽  
T. Rappa ◽  
A. Satriano ◽  
...  
2017 ◽  
Vol 2 (2) ◽  

Laparoscopic sleeve gastrectomy (LSG) is a restrictive bariatric procedure effective for the management of morbid obesity. Staple line leak is the most feared complication after LSG and can present early or late following operation. Untreated, chronic staple line leak (>12 weeks) can lead to abscess formation, which in turn form a fistulous tract to adjacent epithelial lined structures. Herein, we present a case of gastro-colic fistula following leak from LSG treated at our department. A 49 years old male patient, presented 14 weeks after LSG to our emergency department with fever and upper abdominal pain. Imaging studies revealed intra-abdominal abscess between the stomach and the spleen with oral contrast leakage into the abscess cavity. An endoscopic evaluation revealed a fistula distal to the gastro-esophageal junction. Endoscopic management of the fistula done by over the scope clip (OTSC), which later failed. The patient re-admitted 12 weeks later and re-imaging studies showed a gastro-colic fistula and distal stenosis of the gastric sleeve. Endoscopic treatment was completed by OTSC closure of the fistula opening on the stomach side and hem clip closure of the fistula opening on the colon side. Also, fluoroscopically-guided endoscopic balloon dilation was done to treat distal stenosis. At 30 months follow up, the patient is doing well.


2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Anthony Dakwar ◽  
Ahmad Assalia ◽  
Iyad Khamaysi ◽  
Yoram Kluger ◽  
Ahmad Mahajna

Laparoscopic sleeve gastrectomy (LSG) is gaining popularity for the treatment of morbid obesity. It is a simple, low-cost procedure resulting in significant weight loss within a short period of time. LSG is a safe procedure with a low complication rate. The complications encountered nevertheless can result in morbidity and even mortality. The most significant complications are staple-line bleeding, stricture, and staple-line leak. The purpose of this paper is to present a patient who suffered from a staple-line leak presenting 16 months after LSG. Review of the current literature regarding this complication as well as outline of a strategy for the management of post-LSG gastric leaks is suggested.


2020 ◽  
Author(s):  
Amyt Horn ◽  
Ahmad Assalia ◽  
Sa'd Sayida ◽  
Ahmad Mahajna

Abstract Background Gastric leak post laparoscopic sleeve gastrectomy (LSG) is a severe complication that may lead to sepsis and even to patient's death. Early diagnosis and treatment are critical. It was hypnotized that the appearance of high levels of amylase, especially in the drain, may indicate a leak from the gastric staple line. The purpose of this prospective study was to examine the incidence of Amylase increase in the blood, urine and drain fluid, after LSG and to examine whether the appearance of high levels of Amylase indicates the existence of a major complication and especially a leak from the staple line. Methods From 161 patients whom underwent Sleeve gastrectomy, we prospectively evaluated the demographic information, including Body-mass-index (BMI), comorbidities, complications during the surgery or hospitalization, laboratory data including complete blood count, liver function tests, glucose and Amylase levels in blood, urine and drain. Testing for the normal distribution of the variables was performed using Kolmogorov-Smirnov test. Based on the results of this test we performed T- test or Mann-Whitney test to find differences between groups. Multivariate analysis using logistic regression was performed to examine the independent variables which can predict a rise in Amylase values above the upper limit number (ULN). Results Of 161 patients in this study, 35 patients (21.8%) had a rise in the Amylase values in blood, urine and/or drain, and 126 patients (78.2%) had normal values of Amylase until discharge. Amylase rise has been found to be correlated with Neutrophilia (OR = 5.4, p = 0.003), indirect hyperbilirubinemia (OR = 3.9, p = 0.022) and a decline in phosphate level (OR = 2.48, p = 0.019). Furthermore, a rise in Amylase is significantly associated to a rise in Aspartate and Aspartate transaminase transaminases (AST and ALT), Gamma-Glutamyl Transferase (GGT), Creatine-phosphokinase (CPK), Glucose and leukocytes, and a decline in lymphocytes and Calcium. No significant change was found in the duration of the operation and neither in the length of hospitalization. No specific complication was found to be significantly higher in any of the groups. One patient suffered from staple line leak and was treated conservatively. The diagnosis was done in post- operative day three by abdominal CT-scan. The amylase levels in the blood and the drain were normal and only a slight increase of amylase in urine was measured. Conclusions Increase in Amylase after LSG doesn't necessarily indicate a major complication such as staple line leak and in the vast majority of cases, it seems to have no clinical relevancy. Therefore, it should not automatically lead to a full clinical investigation in the absence of further clinical signs. Our results suggest that there is no clinical justification for Amylase tests in any method after LSG.


2021 ◽  
Author(s):  
Rami Archid ◽  
Fateh Bazerbachi ◽  
Barham K. Abu Dayyeh ◽  
Felix Hönes ◽  
Suhaib J. S. Ahmad ◽  
...  

Abstract Purpose Staple line leak (SLL) is a serious complication after sleeve gastrectomy (SG). Common endoscopic treatment options include self-expandable metallic stent (SEMS), endoscopic internal drainage (EID), and endoscopic closure. The endoscopic negative pressure therapy (ENPT) is a promising treatment option combining temporary sealing of the defect with drainage of the inflammatory bed. In this study, we compare the outcome of ENPT and SEMS for the treatment of SLL following SG. Materials and Methods A retrospective cohort of 27 patients (21 females) treated at a single center for SLL after SG was included. ENPT was primary therapy for 14 patients and compared with 13 patients treated primarily using SEMS. Results ENPT was associated with a significant reduction of hospital stay (19 ± 15.1 vs. 56.69 ± 47.21 days, p = 0.027), reduced duration of endoscopic treatment (9.8 ± 8.6 vs. 44.92 ± 60.98 days, p = 0.009), and shorter transabdominal drain dwell time (15 (5–96) vs. 45 (12–162) days, p = 0.014) when compared to SEMS. Whereas endoscopic management was successful in 12/14 (85.7%) of patients from the ENPT group, SEMS was successful in only 5/13 (38.5%) of patients (p = 0.015). Furthermore, ENPT was associated with a significant reduction of endoscopic adverse events compared with SEMS (14.3% vs. 76.92% p = 0.001). Conclusion Compared with SEMS, ENPT is effective and safe in treating SLL after SG providing higher success rates, shorter treatment duration, and lower adverse events rates.


Sign in / Sign up

Export Citation Format

Share Document